Clinical Trial Update: Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, metabolism, and antioxidant activity of silymarin and green tea extract in patients with chronic hepatitis C; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)
• Silymarin (silymarin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Chronic Hepatitis C, Oxidative Stress | Phase 1 | Status: COMPLETED